RVL Pharmaceuticals plc

RVLPNASDAQ·USD·Closed

RVLPNASDAQ·USD·Closed

$0.03

−32.05%

$0.03

−$0.01 (32.05%)

52W Range

2thpctl

Volume

2.62×avg

Mkt Cap

3.14MUSD

P/E

-0.0TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

2thpctl

Volume

2.62×avg

Market Cap

3.14MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+184.1% / yr

Operating margin-91.9%

ROIC-41.3%

Financially safe

Stretched

Debt / equity1.13×

Interest coverage-14.7×

Current ratio2.89×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required